The landmark JDRF continuous glucose monitoring randomized trials: A look back at the accumulated evidence

Journal of Cardiovascular Translational Research

Volumn 5, Issue 4, 2012, Pages 380-387

  Tamborlane, William V ^b   Beck, Roy W ^o   Laffel, Lori ^o   Ruedy, Katrina J ^a   Chase, H Peter ^c   Fiallo Scharer, Rosanna ^c   Messer, Laurel ^c   Gage, Victoria ^c   Burdick, Patricia ^c   Milaszewski, Kerry ^d   Pratt, Katherine ^d   Bismuth, Elise ^d   Keady, Joyce ^d   Lawlor, Margie ^d   Buckingham, Bruce ^e   Wilson, Darrell M ^e   Block, Jennifer ^e   Benassi, Kari ^e   Tsalikian, Eva ^f   Tansey, Michael ^f   Kucera, Debra ^f   Coffey, Julie ^f   Cabbage, Joanne ^f   Wolpert, Howard ^d   Shetty, Greeshma ^d   Atakov Castillo, Astrid ^d   Giusti, Judith ^d   O'Donnell, Stacey ^d   Ghiloni, Suzanne ^d   Hirsch, Irl B ^g   Gilliam, Lisa K ^g   Fitzpatrick, Kathy ^g   Khakpour, Dori ^g   Wysocki, Tim ^h   Fox, Larry A ^h   Mauras, Nelly ^h   Englert, Kimberly ^h   Permuy, Joe ^h   Bode, Bruce W ⁱ   O'Neil, Kelli ⁱ   Tolbert, Lisa ⁱ   Lawrence, Jean M ^j   Clemons, Robert ^j   Maeva, Michelle ^j   Sattler, Bonnie ^j   Weinzimer, Stuart ^b   Ives, Brett ^b   Bosson Heenan, Joan ^b   Kollman, Craig ^a   Xing, Dongyuan ^a   Jackson, Judy ^a   Steffes, Michael ^k   Bucksa, Jean M ^k   Nowicki, Maren L ^k   Van Hale, Carol ^k   Makky, Vicky ^k   O'Grady, Michael ^l   Huang, Elbert ^l   Basu, Anirban ^l   Meltzer, David O ^l   Zhao, Lan ^l   Lee, Joyce ^m   Kowalski, Aaron J ⁿ   Weinstock, Ruth S ^p   Anderson, Barbara J ^p   Kruger, Davida ^p   LaVange, Lisa ^p   Rodriguez, Henry ^p   more..

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h NEMOURS CHILDREN S CLINIC   (United States)

ⁱ ATLANTA DIABETES ASSOCIATES   (United States)

^j Departments of Pediatric Endocrinology and Research and Evaluation   (United States)

^k University of Minnesota Central Laboratory   (United States)

^l UNIVERSITY OF CHICAGO   (United States)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ Juvenile Diabetes Research Foundation Inc   (United States)

^o Juvenile Diabetes Research Foundation Inc ^*  (United States)

^p Data and Safety Monitoring Board   (United States)

more..

Author keywords

Continuous glucose monitoring; Glycated hemoglobin; Hypoglycemia; Psychosocial factors; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS BLOOD GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL ASSESSMENT; MONITOR; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MULTICENTER STUDIES AS TOPIC; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84866114222     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9364-9     Document Type: Article

References (21)

1. The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. The New England Journal of Medicine, 329, 977-986.
2. The Diabetes Control and Complications Trial Research Group. (1994). Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Journal of Pediatrics, 125, 177-188.
3. The Diabetes Control and Complications Trial Research Group. (1995). Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care, 18, 1415-1427.
4. Diabetes Research in Children Network (DirecNet) Study Group. (2005). A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care, 28, 1101-1106.
5. JDRF CGM Study Group. (2008). JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods. Diabetes Technology & Therapeutics, 10, 310-321.
6. Beck, R. W., Lawrence, J. M., Laffel, L., Wysocki, T., Xing, D., Huang, E. S., Ives, B., Kollman, C., Lee, J., Ruedy, K. J., & Tamborlane, W. V. (2010). Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care, 33(10), 2175-2177.
7. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2010). Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technology & Therapeutics, 12(9), 679-684.
8. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England Journal of Medicine, 359, 1464-1476.
9. The DCCT Research Group. (1991). Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. American Journal of Medicine, 90, 450-459.
10. Beck, R. W., Hirsch, I. B., Laffel, L., Tamborlane, W. V., Bode, B. W., Buckingham, B., Chase, P., Clemons, R., Fiallo-Scharer, R., Fox, L. A., Gilliam, L. K., Huang, E. S., Kollman, C., Kowalski, A. J., Lawrence, J. M., Lee, J., Mauras, N., O'Grady, M., Ruedy, K. J., Tansey, M., Tsalikian, E., Weinzimer, S. A., Wilson, D. M., Wolpert, H., Wysocki, T., & Xing, D. (2009). The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 32(8), 1378-1383.
11. The Diabetes Control and Complications Trial Research Group. (1997). Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes, 46, 271-286.
12. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 32, 1378-1383.
13. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care, 32, 1947-1953.
14. Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, K. L. (2003). The PedsQL™ in type 1 and type 2 diabetes: Reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Type 1 Diabetes Module. Diabetes Care, 26, 631-637.
15. Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39(8), 800-812.
16. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). Sustained benefit of continuous glucose monitoring on HbA1c, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care, 32, 2047-2049.
17. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2010). Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care, 33(1), 17-22.
18. Tansey, M., Laffel, L., Cheng, J., Beck, R., Coffey, J., Huang, E., Kollman, C., Lawrence, J., Lee, J., Ruedy, K., Tamborlane, W., Wysocki, T., & Xing, D. (2011). Satisfaction with continuous glucose monitoring in adults and youths with type 1 diabetes. Diabetic Medicine, 28(9), 1118-1122.
19. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2011). Factors predictive of severe hypoglycemia in type 1 diabetes. Diabetes Care, 34(3), 586-590.
20. Chase, H. P., Beck, R. W., Xing, D., Tamborlane, W. V., Coffey, J., Fox, L. A., Ives, B., Keady, J., Kollman, C., Laffel, L., & Ruedy, K. J. (2010). Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technology & Therapeutics, 12(7), 507-515.
21. Huang, E. S., O'Grady, M., Basu, A., Winn, A., John, P., Lee, J., Meltzer, D., Kollman, C., Laffel, L., Tamborlane,W.,Weinzimer, S., & Wysocki, T. (2010). The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care, 33(6), 1269-1274.